[en] We asked whether the antiangiogenic action of 16K human PRL (hPRL), in addition to blocking mitogen-induced vascular endothelial cell proliferation, involved activation of programmed cell death. Treatment with recombinant 16K hPRL increased DNA fragmentation in cultured bovine brain capillary endothelial (BBE) and human umbilical vein endothelial (HUVE) cells in a time- and dose-dependent fashion, independent of the serum concentration. The activation of apoptosis by 16K hPRL was specific for endothelial cells, and the activity of the peptide could be inhibited by heat denaturation, trypsin digestion, and immunoneutralization, but not by treatment with the endotoxin blocker, polymyxin-B. 16K hPRL-induced apoptosis was correlated with the rapid activation of caspases 1 and 3 and was blocked by pharmacological inhibition of caspase activity. Caspase activation was followed by inactivation of two caspase substrates, poly(ADP-ribose) polymerase (PARP) and the inhibitor of caspase-activated deoxyribonuclease (DNase) (ICAD). Furthermore, 16K hPRL increased the conversion of Bcl-X to its proapoptotic form, suggesting that the Bcl-2 protein family may also be involved in 16K hPRL-induced apoptosis. These findings support the hypothesis that the antiangiogenic action of 16K hPRL includes the activation of programmed cell death of vascular endothelial cells.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Martini, J. F.
Piot, C.
Humeau, L. M.
Struman, Ingrid ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Martial, Joseph ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Weiner, R. I.
Language :
English
Title :
The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation
Hanahan D., Folkman J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
Folkman J. (1995) Angiogenesis inhibitors generated by tumors. Mol Med 1:120-122.
Pepper M.S. (1997) Manipulating angiogenesis. From basic science to the bedside. Arterioscler Thromb Vasc Biol 17:605-619.
Esch F., Baird A., Ling N., Ueno N., Hill F., Denoroy L., Klepper R., Gospodarowicz D., Bohlen P., Guillemin R. (1985) Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 82:6507-6511.
Ferrara N., Henzel W.J. (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858.
Fett J.W., Strydom D.J., Lobb R.R., Alderman E.M., Bethune J.L., Riordan J.F., Vallee B.L. (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24:5480-5486.
Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., Yancopoulos G.D. (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169.
Maione T.E., Gray G.S., Petro J., Hunt A.J., Donner A.L., Bauer S.I., Carson H.F., Sharpe R.J. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77-79.
Good D.J., Polverini P.J., Rastinejad F., Le Beau M.M., Lemons R.S., Frazier W.A., Bouck N.P. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628.
Ferrara N., Clapp C., Weiner R. (1991) The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129:896-900.
Clapp C., Martial J.A., Guzman R.C., Rentier-Delure F., Weiner R.I. (1993) The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292-1299.
O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., Folkman J. (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328.
O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285.
Struman I., Bentzien F., Lee H., Mainfroid V., D'Angelo G., Goffin V., Weiner R.I., Martial J.A. (1999) Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 96:1246-1251.
Clapp C., Weiner R.I. (1992) A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology 130:1380-1386.
D'Angelo G., Struman I., Martial J., Weiner R.I. (1995) Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 92:6374-6378.
D'Angelo G., Martini J.F., Liri T., Fantl W.J., Martial J., Weiner R.I. (1999) 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells. Mol Endocrinol 13:692-704.
Pepper M.S., Vassalli J.D., Montesano R., Orci L. (1987) Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 105:2535-2541.
Lee H., Struman I., Clapp C., Martial J., Weiner R.I. (1998) Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: Activation of plasminogen activator inhibitor 1 expression. Endocrinology 139:3696-3703.
Claesson-Welsh L., Welsh M., Ito N., Anand-Apte B., Soker S., Zetter B., O'Reilly M., Folkman J. (1998) Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA 95:5579-5583.
Guo N., Krutzsch H.C., Inman J.K., Roberts D.D. (1997) Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 57:1735-1742.
Cryns V., Yuan J. (1998) Proteases to die for. Genes Dev 12:1551-1570.
Gagliardini V., Fernandez P.A., Lee R.K., Drexler H.C., Rotello R.J., Fishman M.C., Yuan J. (1994) Prevention of vertebrate neuronal death by the crmA gene. Science 263:826-828.
Au J.L., Panchal N., Li D., Gan Y. (1997) Apoptosis: A new pharmacodynamic endpoint. Pharmacol Res 14:1659-1671.
Bannerman D.D., Sathyamoorthy M., Goldblum S.E. (1998) Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins. J Biol Chem 273:35371-35380.
Lawson J.A., Fisher M.A., Simmons C.A., Farhood A., Jaeschke H. (1998) Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury. Hepatology 28:761-767.
Thome M., Hofmann K., Burns K., Martinon F., Bodmer J.L., Mattmann C., Tschopp J. (1998) Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol 8:885-888.
Krishnamoorthy R.R., Crawford M.J., Chaturvedi M.M., Jain S.K., Aggarwal B.B., Al-Ubaidi M.R., Agarwal N. (1999) Photo-oxidative stress down-modulates the activity of nuclear factor-kappaB via involvement of caspase-1, leading to apoptosis of photoreceptor cells. J Biol Chem 274:3734-3743.
Slee E.A., Zhu H., Chow S.C., MacFarlane M., Nicholson D.W., Cohen G.M. (1996) Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 315:21-24.
Liu X., Zou H., Slaughter C., Wang X. (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-184.
Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50.
Adams J.M., Cory S. (1998) The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322-1326.
Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., Thompson C.B. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
Gallicchio M., Hufnagl P., Wojta J., Tipping P. (1996) IFN-gamma inhibits thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in human endothelial cells. J Immunol 157:2610-2617.
Messmer U.K., Briner V.A., Pfeilschifter J. (1999) Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 55:2322-2337.
Harlan J.M., Harker L.A., Striker G.E., Weaver L.J. (1983) Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res 29:15-26.
Oliver F.J., De la Rubia G., Rolli V., Ruiz-Ruiz M.C., De Murcia G., Murcia J.M. (1998) Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273:33533-33539.
Tang D., Kidd V.J. (1998) Cleavage of DFF-45/ICAD by multiple caspases is essential for its function during apoptosis. J Biol Chem 273:28549-28552.
Lee H.H., Dadgostar H., Cheng Q., Shu J., Cheng G. (1999) NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci USA 96:9136-9141.
Panetti T.S., Chen H., Misenheimer T.M., Getzler S.B., Mosher D.F. (1997) Endothelial cell mitogenesis induced by LPA: Inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 129:208-216.
Hugo C.P., Pichler R.P., Schulze-Lohoff E., Prols F., Adler S., Krutsch H.C., Murphy-Ullrich J.E., Couser W.G., Roberts D.D., Johnson R.J. (1999) Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo. Kidney Int 55:2236-2249.
Hudson S.J., Cai J.P., Thomas V., Chin Y.H. (1996) Intracellular signaling of tumor necrosis factor-α in brain microvascular endothelial cells is mediated by a protein tyrosine kinase and protein kinase C-dependent pathway. J Neuroimmunol 70:199-206.
Modur V., Zimmerman G.A., Prescott S.M., McIntyre T.M. (1996) Endothelial cell inflammatory responses to tumor necrosis factor α. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J Biol Chem 271:13094-13102.
Zhang Y., Derynck R. (1999) Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol 9:274-279.
Benjamin L.E., Keshet E. (1997) Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94:8761-8766.
Araki S., Shimada Y., Kaji K., Hayashi H. (1990) Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 168:1194-1200.
Paris N., Rentier-Delrue F., Defontaine A., Goffin V., Lebrun J.J., Mercier L., Martial J.A. (1990) Bacterial production and purification of recombinant human prolactin. Biotechnol Appl Biochem 12:436-449.
Gospodarowicz D., Cheng J., Lirette M. (1983) Bovine brain and pituitary fibroblast growth factors: Comparison of their abilities to support the proliferation of human and bovine vascular endothelial cells. J Cell Biol 97:1677-1685.
Pepper M.S., Montesano R., El Aoumari A., Gros D., Orci L., Meda P. (1992) Coupling and connexin 43 expression in microvascular and large vessel endothelial cells. Am J Physiol 262.
Ryan I.P., Schriock E.D., Taylor R.N. (1994) Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab 78:642-649.